Insider Transactions in Q1 2024 at Karuna Therapeutics, Inc. (KRTX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2024
|
Stephen K. Brannan Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
42,604
-92.39%
|
$14,059,320
$330.0 P/Share
|
|
Mar 18
2024
|
William P Kane Jr Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,828
-68.08%
|
$4,563,240
$330.0 P/Share
|
|
Mar 18
2024
|
William Meury President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
29,379
-67.6%
|
$9,695,070
$330.0 P/Share
|
|
Mar 18
2024
|
Jason Parker Brown Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,167
-83.09%
|
$6,985,110
$330.0 P/Share
|
|
Mar 18
2024
|
Christopher J Coughlin |
SELL
Sale (or disposition) back to the issuer
|
Direct |
990
-100.0%
|
$326,700
$330.0 P/Share
|
|
Mar 18
2024
|
Steven M Paul |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
140,367
-100.0%
|
$46,321,110
$330.0 P/Share
|
|
Mar 18
2024
|
Steven M Paul |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,596
-59.65%
|
$3,496,680
$330.0 P/Share
|
|
Mar 18
2024
|
Andrew Craig Miller President of R&D |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,389
-79.88%
|
$7,718,370
$330.0 P/Share
|
|
Mar 18
2024
|
James Healy |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,381,149
-100.0%
|
$455,779,170
$330.0 P/Share
|
|
Mar 18
2024
|
James Healy |
SELL
Sale (or disposition) back to the issuer
|
Direct |
33,490
-98.52%
|
$11,051,700
$330.0 P/Share
|
|
Mar 18
2024
|
Jeffrey M Jonas |
SELL
Sale (or disposition) back to the issuer
|
Direct |
990
-100.0%
|
$326,700
$330.0 P/Share
|
|
Mar 18
2024
|
Laurie J Olson |
SELL
Sale (or disposition) back to the issuer
|
Direct |
990
-100.0%
|
$326,700
$330.0 P/Share
|
|
Mar 18
2024
|
Atul Pande |
SELL
Sale (or disposition) back to the issuer
|
Direct |
990
-100.0%
|
$326,700
$330.0 P/Share
|
|
Mar 18
2024
|
Denice Torres |
SELL
Sale (or disposition) back to the issuer
|
Direct |
990
-100.0%
|
$326,700
$330.0 P/Share
|
|
Mar 18
2024
|
David E. Wheadon |
SELL
Sale (or disposition) back to the issuer
|
Direct |
990
-100.0%
|
$326,700
$330.0 P/Share
|
|
Mar 08
2024
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.26%
|
$1,590,000
$318.64 P/Share
|
|
Mar 08
2024
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+5.24%
|
$622,500
$83.02 P/Share
|
|
Mar 04
2024
|
Steven M Paul |
BUY
Bona fide gift
|
Indirect |
30,304
+50.0%
|
-
|
|
Mar 04
2024
|
Steven M Paul |
SELL
Bona fide gift
|
Indirect |
30,304
-92.76%
|
-
|
|
Mar 01
2024
|
Steven M Paul |
BUY
Bona fide gift
|
Indirect |
60,608
+49.06%
|
-
|
|
Mar 01
2024
|
Steven M Paul |
SELL
Bona fide gift
|
Indirect |
60,608
-59.05%
|
-
|
|
Feb 29
2024
|
Steven M Paul |
BUY
Other acquisition or disposition
|
Indirect |
47,378
+40.16%
|
$14,924,070
$315.18 P/Share
|
|
Feb 23
2024
|
Steven M Paul |
BUY
Exercise of conversion of derivative security
|
Direct |
31,518
+25.31%
|
$1,670,454
$53.5 P/Share
|
|
Feb 13
2024
|
Jason Parker Brown Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
278
-1.3%
|
$88,404
$318.0 P/Share
|
|
Feb 09
2024
|
Stephen K. Brannan Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,046
-2.54%
|
$331,582
$317.14 P/Share
|
|
Feb 09
2024
|
Andrew Craig Miller President of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,011
-4.14%
|
$320,487
$317.14 P/Share
|
|
Feb 09
2024
|
Steven M Paul |
SELL
Payment of exercise price or tax liability
|
Direct |
804
-7.05%
|
$254,868
$317.14 P/Share
|
|
Feb 08
2024
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.51%
|
$1,580,000
$316.3 P/Share
|
|
Feb 08
2024
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.75%
|
$435,000
$58.71 P/Share
|
|
Jan 08
2024
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-27.96%
|
$4,740,000
$316.81 P/Share
|
|
Jan 08
2024
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500
+10.72%
|
$1,452,500
$83.02 P/Share
|